Detalles de la búsqueda
1.
Development of Human Immunodeficiency Virus Type 1 Resistance to 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine Starting with Wild-Type or Nucleoside Reverse Transcriptase Inhibitor-Resistant Strains.
Antimicrob Agents Chemother
; 65(12): e0116721, 2021 11 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34516245
2.
Oral administration of the nucleoside EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine) provides rapid suppression of HIV viremia in humanized mice and favorable pharmacokinetic properties in mice and the rhesus macaque.
Antimicrob Agents Chemother
; 59(7): 4190-8, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25941222
3.
Evaluation of Combinations of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine with Clinically Used Antiretroviral Drugs.
Antimicrob Agents Chemother
; 57(9): 4554-4558, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23796932
4.
HIV-1 Resistance to Islatravir/Tenofovir Combination Therapy in Wild-Type or NRTI-Resistant Strains of Diverse HIV-1 Subtypes.
Viruses
; 15(10)2023 09 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37896768
5.
Response of simian immunodeficiency virus to the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine in vitro and in vivo.
Antimicrob Agents Chemother
; 56(9): 4707-12, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22713337
6.
Neuropathogenic SIVsmmFGb genetic diversity and selection-induced tissue-specific compartmentalization during chronic infection and temporal evolution of viral genes in lymphoid tissues and regions of the central nervous system.
AIDS Res Hum Retroviruses
; 26(6): 663-79, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20518690
7.
Reduced genetic diversity in lymphoid and central nervous system tissues and selection-induced tissue-specific compartmentalization of neuropathogenic SIVsmmFGb during acute infection.
AIDS Res Hum Retroviruses
; 25(6): 583-601, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19500015
Resultados
1 -
7
de 7
1
Próxima >
>>